Last reviewed · How we verify

NCT05227859

Which is Better Piezosurgery or LLLT in Accelerating Orthodontic Tooth Movement

Completed NA Last updated 13 January 2026
What this trial tests

NA trial testing Piezocision in Class II Malocclusion in 60 participants. Completed in 26 November 2021.

Timeline
8 November 2020
Primary endpoint
28 April 2021
26 November 2021

Quick facts

Lead sponsorDamascus University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date8 November 2020
Primary completion28 April 2021
Estimated completion26 November 2021
Sites1 location across Syria

Drugs / interventions tested

Conditions studied

Sponsor

Damascus University

Who can join

Adults 17 to 28, any sex, with Class II Malocclusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sixty patients requiring extraction-based treatment of the maxillary first premolars, followed by retraction of the maxillary canines, will be randomly assigned to three groups: piezocision, low-level laser therapy, and control. In each group, canine retraction will be initiated after completion of the leveling and alignment phase, using closed nickel-titanium coil springs that apply 150 g of force per side. For anchorage, a soldered transpalatal arch will be used. Pre- and post-distalization dental casts will be assessed to evaluate the rate of canine retraction, canine rotation, and anchorage loss over the follow-up period until a Class I canine relationship is achieved. Periodontal health will be assessed before and after canine retraction by evaluating the following parameters: plaque index, gingival index, bleeding index, and probing depth.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Piezocision

Trials testing the same drug.

Other recruiting trials for Class II Malocclusion

Currently open trials in the same condition.

Other Damascus University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05227859.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing